[Huaren Pharmaceutical: subsidiary terbutaline Sulfate injection obtains Drug Registration Certificate] June 1, Huaren Pharmaceutical announced that Anhui Star Pharmaceutical, a wholly owned subsidiary, received the "Drug Registration Certificate" for terbutaline sulfate injection (1ml:0.5mg specification) and terbutaline sulfate injection (5ml:2.5mg specification) approved and issued by the State Drug Administration.